Z-1048-2023 Class II Ongoing

Recalled by W L Gore & Associates, Inc. — Flagstaff, AZ

FDA device recall Z-1048-2023 was initiated by W L Gore & Associates, Inc. on Dec 14, 2022 and is designated Class II. Reason for recall: Septal Occluders released with incomplete quality test documentation that assesses the release of the device from the delivery system during the index procedure. A potential failure of this quality… The recall status is ongoing. Affected quantity: 14.

Recall details

Product Type
Devices
Report Date
Feb 8, 2023
Initiation Date
Dec 14, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14

Product description

GORE CARDIOFORM Septal Occluder, REF: GSX0030A

Reason for recall

Septal Occluders released with incomplete quality test documentation that assesses the release of the device from the delivery system during the index procedure. A potential failure of this quality test could potentially result could result in occluder embolization, anoxic brain injury, central venous or arterial perforation or rupture.

Distribution pattern

US Nationwide distribution in the states of NY, CA, FL, CT, TX, AR, IN, MA, MO, SD, VA.

Code information

UDI-DI/Serial Numbers: 00733132631032/25556388, 25556389, 25556390, 25556391, 25556392, 25556393, 25556394, 25556398, 25556399, 25556400, 25556401, 25556402, 25556403, 25556406

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1048-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1048-2023. Report a data issue: hello@regdatalab.com.